Azerbaijan vs Singapore: Antiretroviral therapy coverage
Azerbaijan
86.0%
in 2024
Singapore
86.0%
in 2023
Azerbaijan rank
33rd
Singapore rank
33rd
Antiretroviral therapy coverage over time
- Azerbaijan
- Singapore
How they compare
Azerbaijan currently reports 86.0% against 86.0% in Singapore, a difference of 0.0%.
Across all 23 years both countries report, Singapore has been ahead every year.
Azerbaijan ranks 33rd and Singapore ranks 33rd of 143 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 19.4% | 18.8% | Singapore |
| 2010s | 26.3% | 69.9% | 43.6% | Singapore |
| 2020s | 67.2% | 85.0% | 17.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Azerbaijan or Singapore?
- Azerbaijan, at 86.0% against 86.0% in Singapore as of 2024.
- What is the difference in antiretroviral therapy coverage between Azerbaijan and Singapore?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Singapore?
- 23 years are reported by both, from 2000 to 2023.
- How do Azerbaijan and Singapore rank globally for antiretroviral therapy coverage?
- Azerbaijan ranks 33rd and Singapore ranks 33rd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.